hamster |
LD50 |
intraperitoneal |
364mg/kg (364mg/kg) |
? |
Archives of Toxicology. Vol. 32, Pg. 1, 1974. |
man |
TDLo |
oral |
40mg/kg/1W-I (40mg/kg) |
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Archives of Dermatology. Vol. 122, Pg. 1413, 1986. |
mouse |
LD50 |
intraperitoneal |
80mg/kg (80mg/kg) |
? |
Cancer Research. Vol. 42, Pg. 122, 1982. |
mouse |
LD50 |
intravenous |
80mg/kg (80mg/kg) |
? |
Cancer Research. Vol. 42, Pg. 122, 1982. |
mouse |
LD50 |
oral |
260mg/kg (260mg/kg) |
? |
Cesko-Slovenska Farmacie. Vol. 14, Pg. 389, 1965. |
mouse |
LD50 |
subcutaneous |
100mg/kg (100mg/kg) |
IMMUNOLOGICAL INCLUDING ALLERGIC: DECREASE IN HUMORAL IMMUNE RESPONSE |
Journal of Medicinal Chemistry. Vol. 18, Pg. 320, 1975. |
rat |
LD50 |
intraperitoneal |
159mg/kg (159mg/kg) |
? |
Acta Poloniae Pharmaceutica. For English translation, see APPFAR. Vol. 41, Pg. 571, 1984. |
rat |
LD50 |
intravenous |
250mg/kg (250mg/kg) |
? |
Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1467, 1970. |
rat |
LD50 |
oral |
277mg/kg (277mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 15, Pg. 1037, 1973. |
rat |
LD50 |
parenteral |
250mg/kg (250mg/kg) |
? |
Recent Results in Cancer Research. Vol. 52, Pg. 76, 1975. |
rat |
LD50 |
subcutaneous |
90mg/kg (90mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 15, Pg. 1037, 1973. |